Supernus Pharmaceuticals, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 10.07 M | $313.89 M | 100.00% | 18.25% |
VANGUARD GROUP INC | 11/13/2024 | 6.13 M | $191.07 M | -0.16% | 11.11% |
ARMISTICE CAPITAL, LLC | 11/14/2024 | 5.10 M | $158.89 M | -3.34% | 9.24% |
DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 2.88 M | $89.87 M | 0.54% | 5.23% |
MACQUARIE GROUP LTD | 11/14/2024 | 2.63 M | $82.06 M | -1.79% | 4.77% |
STATE STREET CORP | 11/14/2024 | 2.16 M | $67.24 M | -0.34% | 3.91% |
POLAR CAPITAL HOLDINGS PLC | 11/14/2024 | 1.94 M | $60.42 M | -0.13% | 3.51% |
STEPHENS INVESTMENT MANAGEMENT GROUP LLC | 10/28/2024 | 1.93 M | $60.25 M | 1.78% | 3.50% |
PACER ADVISORS, INC. | 11/12/2024 | 1.75 M | $54.65 M | 29.86% | 3.18% |
RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 1.73 M | $53.90 M | 2.58% | 3.13% |
LOOMIS SAYLES & CO L P | 11/13/2024 | 1.52 M | $47.27 M | -2.57% | 2.75% |
GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.48 M | $46.22 M | 5.29% | 2.69% |
GW&K INVESTMENT MANAGEMENT, LLC | 11/07/2024 | 1.24 M | $38.60 M | -4.28% | 2.24% |
ARISTOTLE CAPITAL BOSTON, LLC | 11/14/2024 | 1.19 M | $37.24 M | -0.74% | 2.17% |
AMERICAN CENTURY COMPANIES INC | 11/12/2024 | 1.04 M | $32.58 M | 108.29% | 1.89% |
GOLDMAN SACHS GROUP INC | 11/14/2024 | 899,637 | $28.05 M | 52.39% | 1.63% |
VICTORY CAPITAL MANAGEMENT INC | 11/05/2024 | 742,871 | $23.16 M | 1.07% | 1.35% |
MORGAN STANLEY | 11/14/2024 | 726,113 | $22.64 M | 8.28% | 1.32% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 712,395 | $22.21 M | 14.71% | 1.29% |
PICTET ASSET MANAGEMENT HOLDING SA | 11/12/2024 | 560,595 | $17.24 M | 2.69% | 1.02% |
AMERIPRISE FINANCIAL INC | 11/14/2024 | 546,055 | $17.03 M | -3.25% | 0.99% |
ASHFORD CAPITAL MANAGEMENT INC | 11/18/2024 | 544,035 | $16.96 M | -23.58% | 0.99% |
RICE HALL JAMES & ASSOCIATES, LLC | 10/28/2024 | 540,788 | $16.86 M | 7.60% | 0.98% |
SCHRODER INVESTMENT MANAGEMENT GROUP | 11/13/2024 | 515,297 | $15.85 M | 1.42% | 0.93% |
INVESCO LTD. | 11/12/2024 | 486,042 | $15.15 M | -17.44% | 0.88% |
D. E. SHAW & CO., INC. | 11/14/2024 | 408,788 | $12.75 M | 40.58% | 0.74% |
BANK OF AMERICA CORP /DE/ | 11/14/2024 | 375,414 | $11.71 M | -7.44% | 0.68% |
BANK OF NEW YORK MELLON CORP | 11/12/2024 | 372,450 | $11.61 M | -12.44% | 0.68% |
TRIBUTARY CAPITAL MANAGEMENT, LLC | 10/24/2024 | 344,319 | $10.74 M | -0.23% | 0.62% |
SEI INVESTMENTS CO | 11/12/2024 | 313,740 | $9.78 M | -7.08% | 0.57% |
PRINCIPAL FINANCIAL GROUP INC | 10/31/2024 | 285,411 | $8.90 M | 5.38% | 0.52% |
JPMORGAN CHASE & CO | 11/08/2024 | 253,396 | $7.90 M | 40.56% | 0.46% |
MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 252,743 | $7.88 M | 56.66% | 0.46% |
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 11/08/2024 | 214,864 | $6.70 M | 145.72% | 0.39% |
SCOUT INVESTMENTS, INC. | 11/12/2024 | 208,613 | $6.88 M | -13.91% | 0.38% |
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC | 11/06/2024 | 202,654 | $6.32 M | -27.22% | 0.37% |
PEREGRINE CAPITAL MANAGEMENT LLC | 10/24/2024 | 199,652 | $6.23 M | -1.31% | 0.36% |
THIRD AVENUE MANAGEMENT LLC | 11/14/2024 | 189,493 | $5.91 M | 0.20% | 0.34% |
WOODLINE PARTNERS LP | 11/14/2024 | 188,571 | $5.88 M | 100.00% | 0.34% |
LEGAL & GENERAL GROUP PLC | 11/14/2024 | 171,765 | $5.36 M | 9.32% | 0.31% |
RHUMBLINE ADVISERS | 11/12/2024 | 171,644 | $5.35 M | -4.79% | 0.31% |
DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN | 11/14/2024 | 142,386 | $4.44 M | 0.00% | 0.26% |
CANDRIAM S.C.A. | 11/13/2024 | 141,889 | $4.42 M | 0.00% | 0.26% |
VOLORIDGE INVESTMENT MANAGEMENT, LLC | 11/14/2024 | 137,461 | $4.29 M | -20.20% | 0.25% |
NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 133,224 | $4.15 M | 0.00% | 0.24% |
S&T BANK/PA | 11/13/2024 | 123,333 | $3.85 M | -3.37% | 0.22% |
PUBLIC SECTOR PENSION INVESTMENT BOARD | 11/14/2024 | 116,949 | $3.65 M | -3.31% | 0.21% |
RUSSELL INVESTMENTS GROUP, LTD. | 11/13/2024 | 109,547 | $3.42 M | 9.26% | 0.20% |
PHOCAS FINANCIAL CORP. | 11/07/2024 | 109,460 | $3.41 M | -5.92% | 0.20% |
UBS GROUP AG | 11/14/2024 | 108,858 | $3.39 M | 35.93% | 0.20% |
Supernus Pharmaceuticals, Inc.institutional Ownership - FAQ's
During the previous two years, 371 institutional investors and hedge funds held shares of Supernus Pharmaceuticals, Inc.. The most heavily invested institutionals were:
BlackRock Funding, Inc. /DE: 10.07 M
VANGUARD GROUP INC: 6.13 M
ARMISTICE CAPITAL, LLC: 5.1 M
DIMENSIONAL FUND ADVISORS LP: 2.88 M
MACQUARIE GROUP LTD: 2.63 M
STATE STREET CORP: 2.16 M
108.27% of Supernus Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 81.83 M shares in the last 24 months. This purchase volume represents approximately $2.90 B in transactions.